Bearing in mind that ALDH1 increases chemoresistance against cyclophosphamide, one can argue that this chemotherapeutic agent is not part of the standard chemotherapy regimen against pancreatic cancer. Here, ALDH1A1 is linked to pancreatic neoplasm.